Women have higher levels of CoQ10 than men when supplemented with a single dose of CoQ10 with monoglycerides omega-3 or rice oil and followed for 48 h: a crossover randomised triple blind controlled study
Authors:
Open Access
- 18 January 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Nutritional Science
- Vol. 11, e2
Abstract
Coenzyme Q10 (CoQ10), a lipid involved in ATP synthesis, exhibits very limited oral absorption, and its endogenous production decreases with ageing and with the occurrence of oxidative stress. Our group previously showed that monoglycerides omega-3 (MAG-OM3) increase OM3 plasma concentrations. Since CoQ10 is liposoluble, we hypothesised that its 48 h pharmacokinetics is higher when provided with MAG-OM3 compared to CoQ10 alone (in powder form) or added to rice oil (a neutral triacylglycerol oil). A randomised triple-blind crossover study was performed with fifteen men and fifteen women consuming the three supplements providing 200 mg of CoQ10 in a random order. Blood samples were collected before (t = 0) and 1, 3, 5, 6, 7, 8, 10, 11, 24 and 48 h after the supplement intake. Plasma total CoQ10 concentrations were analysed on ultrahigh-performance liquid chromatography coupled to a tandem mass spectrometer (UPLC-MS/MS). Participants were 26⋅1 ± 4⋅8 years old. When CoQ10 was provided with rice or MAG-OM3 oils, the 48 h area under the curve (AUC 0–48 h) was approximately two times higher compared to when provided without an oil. The delta max concentration (ΔCmax) of plasma CoQ10 was, respectively, 2 (MAG-OM3) and 2⋅5 (rice oil) times higher compared to CoQ10 alone. There was a significant sex by treatment interaction (P = 0⋅0250) for the AUC 0–6 h supporting that in postprandial, men and women do not respond the same way to the different supplement. Women had a higher CoQ10 concentration 48 h after the single-dose intake compared to men. We conclude that CoQ10 supplements must be provided with lipids, and their kinetics is different between men and women.Keywords
Funding Information
- Biodroga Nutraceuticals (no award number)
This publication has 35 references indexed in Scilit:
- Postprandial metabolism of meal triglyceride in humansBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- The Q cycle of cytochrome bc complexes: A structure perspectiveBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)The Journal of Clinical Pharmacology, 2007
- The uptake and distribution of coenzyme Q(10)Mitochondrion, 2007
- Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokineticsFree Radical Research, 2006
- Biological Variation of Coenzyme Q10Clinical Chemistry, 2005
- Sensitive and selective analysis of coenzyme Q10in human serum by negative APCI LC-MSThe Analyst, 2003
- Biochemical, physiological and medical aspects of ubiquinone functionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteersMolecular Aspects of Medicine, 1994
- Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992